Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 4
2019 2
2020 1
2021 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Four-Year Outcomes of Left Main Percutaneous Coronary Intervention with a Bioresorbable Scaffold in the Circumflex Ostium.
Erglis A, Narbute I, Sondore D, Jegere S, Kumsars I, Dombrovskis A, Grikis K, Briede I, Dombrovska K, Trusinskis K, Grave A, Erglis M, Kalejs M, Stradins P, Strazdins U. Erglis A, et al. Among authors: briede i. J Interv Cardiol. 2022 Oct 31;2022:7934868. doi: 10.1155/2022/7934868. eCollection 2022. J Interv Cardiol. 2022. PMID: 36407753 Free PMC article.
Tissue evacuated during joint replacement procedure as a source of mononuclear cells.
Eriks J, Kristaps E, Liene P, Martins E, Dortane R, Rupaine B, Krapse S, Ieva B, Goncars V, Indrikis M, Andrejs E. Eriks J, et al. Among authors: ieva b. Eur J Orthop Surg Traumatol. 2018 Apr;28(3):457-461. doi: 10.1007/s00590-017-2067-9. Epub 2017 Nov 1. Eur J Orthop Surg Traumatol. 2018. PMID: 29094213 Free PMC article.
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries.
Moroni F, Beneduce A, Giustino G, Briede I, Park SJ, Daemen J, Claude Morice M, Nakamura S, Meliga E, Cerrato E, Makkar RR, D'Ascenzo F, Lucarelli C, Capranzano P, Tchetche D, Templin C, Kirtane A, Buzman P, Alfieri O, Valgimigli M, Mehran R, Colombo A, Montorfano M, Chieffo A; DELTA, DELTA 2 Investigators* *. Moroni F, et al. Among authors: briede i. J Am Heart Assoc. 2022 Mar;11(5):e022320. doi: 10.1161/JAHA.121.022320. Epub 2022 Feb 22. J Am Heart Assoc. 2022. PMID: 35189691 Free PMC article.
Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates.
Trusinskis K, Lapsovs M, Paeglite S, Knoka E, Caunite L, Mazule M, Briede I, Jegere S, Kumsars I, Narbute I, Konrade I, Erglis A, Lejnieks A. Trusinskis K, et al. Among authors: briede i. J Clin Transl Res. 2021 Apr 16;7(2):270-276. eCollection 2021 Apr 22. J Clin Transl Res. 2021. PMID: 34104831 Free PMC article.
New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry.
Tanaka A, Giustino G, Briede I, Sawaya FJ, Daemen J, Kawamoto H, Meliga E, D'Ascenzo F, Cerrato E, Stefanini GG, Capodanno D, Mangiameli A, Templin C, Erglis A, Morice MC, Mehran R, Van Mieghem NM, Nakamura S, De Benedictis M, Pavani M, Varbella F, Pisaniello M, Sharma SK, Tamburino C, Tchetche D, Colombo A, Chieffo A; DELTA 2 Investigators. Tanaka A, et al. Among authors: briede i. Int J Cardiol. 2019 Apr 1;280:30-37. doi: 10.1016/j.ijcard.2018.12.003. Epub 2018 Dec 15. Int J Cardiol. 2019. PMID: 30595357 Clinical Trial.
12 results